FIRST TRACKS BIOTHERAPEUTICS INC (TRAX)
NASDAQHealth CareBiotechnologySnapshot 2026-11-05
$45.43-7.36%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-05
QuarterlyIQ Insights · TRAX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | |
|---|---|---|---|
| Operating Expenses & Income | |||
| R&D Expenses | 109.0 | 139.6 | 152.3 |
| Operating Income | (157.4) | (179.0) | (181.1) |
| Earnings from Continuing Operations | |||
| Other Non-Operating Income / Expenses | 7.6 | 12.9 | 17.4 |
| Income Tax Expense | — | 0.0 | 0.0 |
| Net Income | |||
| Net Income | (149.8) | (166.1) | (163.7) |
| Per Share | |||
| Basic EPS | (4.19) | — | — |
| Diluted EPS | (4.19) | — | — |
| Basic Weighted Avg Shares | 35.7 | — | — |
| Diluted Weighted Avg Shares | 35.7 | — | — |
| Supplemental | |||
| EBITDA | — | (178.4) | (180.5) |
| EBIT | (157.4) | (179.0) | (181.1) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.